Context Therapeutics Inc.

Trading Plans

During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act)adopted orterminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(a) of Regulation S-K).

Executive Officer Employment Agreement Amendments

On August 4, 2026, we entered into:

•an amendment (the “Lehr Amendment”) to that certain Amended and Restated Employment Agreement by and between us and Martin Lehr, our Chief Executive Officer, dated October 22, 2021 (the “Lehr Employment Agreement”);

•an amendment (the “Minai-Azary Amendment”) to that certain Employment Agreement by and between us and Jennifer Minai-Azary, our Chief Financial Officer, dated November 1, 2021 (the “Minai-Azary Employment Agreement”); and

•an amendment (the “Levit Amendment”) to that certain Employment Agreement by and between us and Alex Levit, our Chief Legal Officer and Corporate Secretary, dated October 22, 2021 (the “Levit Employment Agreement”).

The Lehr Amendment, the Minai-Azary Amendment and the Levit Amendment are collectively referred to as the “Employment Agreement Amendments.” The Lehr Employment Agreement, the Minai-Azary Employment Agreement and the Levit Employment Agreement are collectively referred to as the “Employment Agreements.”

The Employment Agreement Amendments revised the executives’ change in control severance protections by extending the protection period to include the three months preceding a Change in Control (as defined in the Employment Agreements). As a result, an executive officer who is terminated by us without Cause (as defined in the Employment Agreements) or resigns for Good Reason (as defined in the Employment Agreements) is eligible for change in control severance benefits if such termination or resignation occurs upon, within the three-month period prior to, or within the twelve-month period following a Change in Control (a “Termination Upon a Change in Control”), rather than only upon or within twelve months following a Change in Control.

In addition, the Lehr Amendment increased Mr. Lehr’s medical, vision and dental continuation benefits following a Termination Upon a Change in Control from up to 12 months to up to 18 months.

The foregoing descriptions of the Employment Agreement Amendments do not purport to be complete and are qualified in their entirety by reference to the full text of the Lehr Amendment, the Minai-Azary Amendment and the Levit Amendment, copies of which are attached hereto as Exhibit 10.1, Exhibit 10.2 and Exhibit 10.3, respectively, and are incorporated by reference into this Item 5.